HKSE:02269 (China)  
WuXi Biologics (Cayman) Inc logo

WuXi Biologics (Cayman) Inc

HK$ 71.95 (+3.15%) Aug 17
P/E:
76.47
P/B:
7.73
Market Cap:
HK$ 303.28B ($ 38.67B)
Enterprise V:
HK$ 286.12B ($ 36.48B)
Volume:
8.16M
Avg Vol (2M):
21.52M
Also Trade In:
Volume:
8.16M
Market Cap HK$:
303.28B
Market Cap $:
38.67B
PE Ratio:
76.47
Avg Vol (2-Month):
21.52M
Enterprise Value HK$:
286.12B
Enterprise Value $:
36.48B
PB Ratio:
7.73
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
WuXi Biologics ("WuXi") is a contract development and manufacturing organization, or "CDMO," for biologic drugs. It was founded in 2010 as part of WuXi AppTec and listed on the Hong Kong Stock Exchange in 2017. WuXi provides comprehensive services from conception to commercialization, including drug discovery, clinical and commercial manufacturing, and various support services such as process validation, viral clearance studies, product and cell line characterization, stability studies, and others. It does not conduct clinical trials.

Financials (Next Earnings Date:2022-08-23 Est.)

HKSE:02269's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 12,527.469
EPS (TTM) (HK$) 0.936
Beta 1.41
Volatility % 39.52
14-Day RSI 42.82
14-Day ATR (HK$) 3.735775
20-Day SMA (HK$) 74.31
12-1 Month Momentum % -33.16
52-Week Range (HK$) 40.3 - 127.3
Shares Outstanding (Mil) 4,215.2

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

WuXi Biologics (Cayman) Inc Filings

Document Form Filing Date
No Filing Data